TCG Crossover Management, LLC
Related Filers (5)
- Viridian Therapeutics, Inc.\DE (3)
- Tyra Biosciences, Inc. (2)
- Cogent Biosciences, Inc. (2)
- CymaBay Therapeutics, Inc. (1)
- Silence Therapeutics plc (1)
- Show More ...
Other (9)
13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/18/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (9)
SC 13G
Friday, 8/19/2022
Silence Therapeutics plc: Major Shareholders
SC 13G
Monday, 11/29/2021
CymaBay Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 11/17/2021
Cogent Biosciences, Inc.: Major Shareholders
SC 13G/A
Wednesday, 9/29/2021
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G/A
Wednesday, 9/29/2021
Tyra Biosciences, Inc.: Major Shareholders
SC 13G/A
Friday, 9/24/2021
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G
Tuesday, 9/21/2021
Tyra Biosciences, Inc.: Major Shareholders
SC 13G
Friday, 9/10/2021
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G
Thursday, 7/8/2021
Cogent Biosciences, Inc.: Major Shareholders